194 related articles for article (PubMed ID: 24186001)
1. Association of OGG1 Ser326Cys polymorphism and pancreatic cancer susceptibility: evidence from a meta-analysis.
Yan Y; Chen X; Li T; Li M; Liang H
Tumour Biol; 2014 Mar; 35(3):2397-402. PubMed ID: 24186001
[TBL] [Abstract][Full Text] [Related]
2. Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.
Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
Diagn Pathol; 2014 Jun; 9():108. PubMed ID: 24893568
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.
Zhou PT; Li B; Ji J; Wang MM; Gao CF
Med Oncol; 2015 Feb; 32(2):472. PubMed ID: 25588927
[TBL] [Abstract][Full Text] [Related]
4. Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis.
Zhang Y; He BS; Pan YQ; Xu YQ; Wang SK
Int J Colorectal Dis; 2011 Dec; 26(12):1525-30. PubMed ID: 21695387
[TBL] [Abstract][Full Text] [Related]
5. The association between OGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis of 27 studies.
Duan WX; Hua RX; Yi W; Shen LJ; Jin ZX; Zhao YH; Yi DH; Chen WS; Yu SQ
PLoS One; 2012; 7(4):e35970. PubMed ID: 22540013
[TBL] [Abstract][Full Text] [Related]
6. The OGG1 Ser326Cys polymorphism and the risk of esophageal cancer: a meta-analysis.
Wang Z; Gan L; Nie W; Geng Y
Genet Test Mol Biomarkers; 2013 Oct; 17(10):780-5. PubMed ID: 23909557
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.
Zhong DY; Chu HY; Wang ML; Ma L; Shi DN; Zhang ZD
Genet Mol Res; 2012 Sep; 11(3):3490-6. PubMed ID: 23079842
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.
Guo CL; Han FF; Wang HY; Wang L
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1443-8. PubMed ID: 22526153
[TBL] [Abstract][Full Text] [Related]
9. The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.
Wei B; Zhou Y; Xu Z; Xi B; Cheng H; Ruan J; Zhu M; Hu Q; Wang Q; Wang Z; Yan Z; Jin K; Zhou D; Xuan F; Huang X; Shao J; Lu P
PLoS One; 2011; 6(11):e27545. PubMed ID: 22114677
[TBL] [Abstract][Full Text] [Related]
10. Influence of the OGG1 Ser326Cys polymorphism on oxidatively damaged DNA and repair activity.
Jensen A; Løhr M; Eriksen L; Grønbæk M; Dorry E; Loft S; Møller P
Free Radic Biol Med; 2012 Jan; 52(1):118-25. PubMed ID: 22019439
[TBL] [Abstract][Full Text] [Related]
11. The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case-control studies.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Tumour Biol; 2015 Feb; 36(2):1029-38. PubMed ID: 25323581
[TBL] [Abstract][Full Text] [Related]
12. Association between the OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and lung cancer risk: a meta-analysis.
Wei W; He XF; Qin JB; Su J; Li SX; Liu Y; Zhang Y; Wang W
Mol Biol Rep; 2012 Dec; 39(12):11249-62. PubMed ID: 23065211
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of the association between the hOGG1 Ser326Cys polymorphism and the risk of esophageal squamous cell carcinoma.
Zhang J; Zhou J; Zhang P; Wang W; Tao S; Wang M
PLoS One; 2013; 8(6):e65742. PubMed ID: 23762419
[TBL] [Abstract][Full Text] [Related]
14. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
15. A limited association of OGG1 Ser326Cys polymorphism for adenocarcinoma of the lung.
Ito H; Hamajima N; Takezaki T; Matsuo K; Tajima K; Hatooka S; Mitsudomi T; Suyama M; Sato S; Ueda R
J Epidemiol; 2002 May; 12(3):258-65. PubMed ID: 12164330
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.
Gu D; Wang M; Zhang Z; Chen J
Breast Cancer Res Treat; 2010 Jul; 122(2):527-31. PubMed ID: 20054639
[TBL] [Abstract][Full Text] [Related]
17. The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis.
Li H; Hao X; Zhang W; Wei Q; Chen K
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1739-45. PubMed ID: 18628426
[TBL] [Abstract][Full Text] [Related]
18. Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls.
Guan P; Huang D; Yin Z; Zhou B
Asian Pac J Cancer Prev; 2011; 12(4):1067-72. PubMed ID: 21790253
[TBL] [Abstract][Full Text] [Related]
19. Association between the hOGG1 Ser326Cys polymorphism and lung cancer susceptibility: a meta-analysis based on 22,475 subjects.
Xu Z; Yu L; Zhang X
Diagn Pathol; 2013 Aug; 8():144. PubMed ID: 23971971
[TBL] [Abstract][Full Text] [Related]
20. Association of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis.
Niu Y; Li F; Tang B; Shi Y; Yu P
Mol Biol Rep; 2012 Jun; 39(6):6563-8. PubMed ID: 22294108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
